PROGYNY INC (PGNY) — insider trading
Health Care · NASDAQ
PROGYNY INC (PGNY) has 69 reported SEC Form 4 insider transactions in our data, including 16 open-market sales among the most recent 69 (latest 2026-10-14).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Cummings Melissa B | Officer (Chief Operating Officer) | Open-market sale | 1,879 | $28.00 | $52.6K | Form 4 |
| 2026-10-14 | Cummings Melissa B | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 1,559 | $27.39 | $42.7K | Form 4 |
| 2026-09-23 | Swartz Allison | Officer (EVP, GC) | Open-market sale | 3,903 | $26.10 | $101.9K | Form 4 |
| 2026-09-17 | Clapp Geoffrey | Officer (Chief Product Officer) | Shares withheld for taxes / exercise cost | 819 | $27.38 | $22.4K | Form 4 |
| 2026-09-10 | GORDON KEVIN K | Director | Option exercise / conversion (derivative) | 22,000 | — | $0 | Form 4/A |
| 2026-09-10 | GORDON KEVIN K | Director | Open-market sale | 11,500 | $27.12 | $311.9K | Form 4/A |
| 2026-09-10 | GORDON KEVIN K | Director | Shares withheld for taxes / exercise cost | 10,500 | $27.24 | $286.0K | Form 4/A |
| 2026-09-10 | GORDON KEVIN K | Director | Option exercise / conversion | 22,000 | $13.00 | $286.0K | Form 4/A |
| 2026-09-10 | GORDON KEVIN K | Director | Option exercise / conversion (derivative) | 22,000 | — | $0 | Form 4 |
| 2026-09-10 | GORDON KEVIN K | Director | Open-market sale | 11,500 | $27.94 | $321.4K | Form 4 |
| 2026-09-10 | GORDON KEVIN K | Director | Shares withheld for taxes / exercise cost | 10,500 | $27.24 | $286.0K | Form 4 |
| 2026-09-10 | GORDON KEVIN K | Director | Option exercise / conversion | 22,000 | $13.00 | $286.0K | Form 4 |
| 2026-09-04 | Swartz Allison | Officer (EVP, GC) | Shares withheld for taxes / exercise cost | 479 | $26.61 | $12.7K | Form 4 |
| 2026-09-04 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for taxes / exercise cost | 479 | $26.61 | $12.7K | Form 4 |
| 2026-09-03 | Swartz Allison | Officer (EVP, GC) | Shares withheld for taxes / exercise cost | 828 | $26.29 | $21.8K | Form 4 |
| 2026-09-03 | Anevski Peter | Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for taxes / exercise cost | 5,361 | $26.29 | $140.9K | Form 4 |
| 2026-09-03 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for taxes / exercise cost | 1,532 | $26.29 | $40.3K | Form 4 |
| 2026-09-02 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for taxes / exercise cost | 224 | $25.66 | $5.7K | Form 4 |
| 2026-08-28 | Swartz Allison | Officer (EVP, GC) | Shares withheld for taxes / exercise cost | 1,352 | $25.86 | $35.0K | Form 4 |
| 2026-07-14 | Cummings Melissa B | Officer (Chief Operating Officer) | Open-market sale | 2,244 | $31.60 | $70.9K | Form 4 |
| 2026-07-14 | Cummings Melissa B | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 1,193 | $31.98 | $38.2K | Form 4 |
| 2026-06-17 | Clapp Geoffrey | Officer (Chief Product Officer) | Shares withheld for taxes / exercise cost | 819 | $26.60 | $21.8K | Form 4 |
| 2026-06-04 | Swartz Allison | Officer (EVP, GC) | Open-market sale | 599 | $25.08 | $15.0K | Form 4 |
| 2026-06-04 | Swartz Allison | Officer (EVP, GC) | Shares withheld for taxes / exercise cost | 339 | $24.99 | $8.5K | Form 4 |
| 2026-06-04 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | 599 | $25.50 | $15.3K | Form 4 |
| 2026-06-04 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | 1,918 | $25.50 | $48.9K | Form 4 |
| 2026-06-04 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for taxes / exercise cost | 339 | $24.99 | $8.5K | Form 4 |
| 2026-06-03 | Anevski Peter | Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for taxes / exercise cost | 5,361 | $25.12 | $134.7K | Form 4 |
| 2026-06-03 | Swartz Allison | Officer (EVP, GC) | Open-market sale | 1,199 | $25.02 | $30.0K | Form 4 |
| 2026-06-03 | Swartz Allison | Officer (EVP, GC) | Shares withheld for taxes / exercise cost | 676 | $25.12 | $17.0K | Form 4 |
| 2026-06-03 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for taxes / exercise cost | 1,082 | $25.12 | $27.2K | Form 4 |
| 2026-06-02 | Clapp Geoffrey | Officer (Chief Product Officer) | Option exercise / conversion (derivative) | 12,909 | — | $0 | Form 4 |
| 2026-06-02 | Clapp Geoffrey | Officer (Chief Product Officer) | Shares withheld for taxes / exercise cost | 11,379 | $25.54 | $290.6K | Form 4 |
| 2026-06-02 | Clapp Geoffrey | Officer (Chief Product Officer) | Option exercise / conversion | 12,909 | $20.91 | $269.9K | Form 4 |
| 2026-06-02 | Clapp Geoffrey | Officer (Chief Product Officer) | Open-market sale | 1,530 | $25.58 | $39.1K | Form 4 |
| 2026-06-02 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | 279 | $26.20 | $7.3K | Form 4 |
| 2026-06-02 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for taxes / exercise cost | 158 | $26.20 | $4.1K | Form 4 |
| 2026-06-01 | Scott Cheryl | Director | Option exercise / conversion (derivative) | 14,667 | — | $0 | Form 4 |
| 2026-06-01 | Scott Cheryl | Director | Open-market sale | 7,439 | $26.39 | $196.3K | Form 4 |
| 2026-06-01 | Scott Cheryl | Director | Shares withheld for taxes / exercise cost | 7,228 | $26.38 | $190.7K | Form 4 |
| 2026-06-01 | Scott Cheryl | Director | Option exercise / conversion | 14,667 | $13.00 | $190.7K | Form 4 |
| 2026-05-28 | Swartz Allison | Officer (EVP, GC) | Open-market sale | 2,398 | $25.46 | $61.1K | Form 4 |
| 2026-05-28 | Swartz Allison | Officer (EVP, GC) | Shares withheld for taxes / exercise cost | 1,352 | $25.48 | $34.4K | Form 4 |
| 2026-05-27 | GORDON KEVIN K | Director | Other acquisition or disposition | 2,526 | — | $0 | Form 4 |
| 2026-05-27 | GORDON KEVIN K | Director | Other acquisition or disposition | 2,526 | — | $0 | Form 4 |
| 2026-05-27 | GORDON KEVIN K | Director | Open-market sale | 5,500 | $24.99 | $137.4K | Form 4 |
| 2026-05-21 | MORRIS DEBRA L | Director | Grant / award / vesting (derivative) | 27,119 | — | $0 | Form 4 |
| 2026-05-21 | MORRIS DEBRA L | Director | Grant / award / vesting (derivative) | 3,203 | $12.49 | $40.0K | Form 4 |
| 2026-05-21 | MORRIS DEBRA L | Director | Grant / award / vesting | 5,660 | — | $0 | Form 4 |
| 2026-05-21 | Scott Cheryl | Director | Grant / award / vesting (derivative) | 27,119 | — | $0 | Form 4 |
| 2026-05-21 | Scott Cheryl | Director | Grant / award / vesting | 5,660 | — | $0 | Form 4 |
| 2026-05-21 | Payson Norman | Director | Grant / award / vesting (derivative) | 27,119 | — | $0 | Form 4 |
| 2026-05-21 | Payson Norman | Director | Grant / award / vesting (derivative) | 3,203 | $12.49 | $40.0K | Form 4 |
| 2026-05-21 | Payson Norman | Director | Grant / award / vesting | 5,660 | — | $0 | Form 4 |
| 2026-05-21 | Park Jeffrey G | Director | Grant / award / vesting (derivative) | 31,458 | — | $0 | Form 4 |
| 2026-05-21 | Park Jeffrey G | Director | Grant / award / vesting (derivative) | 5,205 | $12.49 | $65.0K | Form 4 |
| 2026-05-21 | Park Jeffrey G | Director | Grant / award / vesting | 7,924 | — | $0 | Form 4 |
| 2026-05-21 | HOLSTEIN ROGER C | Director | Grant / award / vesting (derivative) | 29,289 | — | $0 | Form 4 |
| 2026-05-21 | HOLSTEIN ROGER C | Director | Grant / award / vesting (derivative) | 4,003 | $12.49 | $50.0K | Form 4 |
| 2026-05-21 | HOLSTEIN ROGER C | Director | Grant / award / vesting | 6,792 | — | $0 | Form 4 |
| 2026-05-21 | GORDON KEVIN K | Director | Grant / award / vesting (derivative) | 30,373 | — | $0 | Form 4 |
| 2026-05-21 | GORDON KEVIN K | Director | Grant / award / vesting | 6,792 | — | $0 | Form 4 |
| 2026-05-21 | Dean Lloyd H | Director | Grant / award / vesting (derivative) | 28,203 | — | $0 | Form 4 |
| 2026-05-21 | Dean Lloyd H | Director | Grant / award / vesting | 6,792 | — | $0 | Form 4 |
| 2026-05-21 | Bierbower Elizabeth D | Director | Grant / award / vesting (derivative) | 27,119 | — | $0 | Form 4 |
| 2026-05-21 | Bierbower Elizabeth D | Director | Grant / award / vesting (derivative) | 3,203 | $12.49 | $40.0K | Form 4 |
| 2026-05-21 | Bierbower Elizabeth D | Director | Grant / award / vesting | 5,660 | — | $0 | Form 4 |
| 2026-05-20 | Livingston Mark S. | Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | 8,275 | $25.50 | $211.0K | Form 4 |
| 2026-05-19 | Cummings Melissa B | Officer (Chief Operating Officer) | Open-market sale | 9,578 | $25.00 | $239.4K | Form 4 |
Ask the chat about PGNY's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: PROGYNY INC (PGNY).
Last updated 2026-10-14 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.